{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:08:23Z","timestamp":1777475303663,"version":"3.51.4"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.neuropharm.2012.05.015","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T05:49:55Z","timestamp":1337752195000},"page":"97-105","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["From genes to cognition in tuberous sclerosis: Implications for mTOR inhibitor-based treatment approaches"],"prefix":"10.1016","volume":"68","author":[{"given":"Dan","family":"Ehninger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.05.015_bib1","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1093\/hmg\/ddr393","article-title":"Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex","volume":"20","author":"Anderl","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib2","first-page":"2018","article-title":"A\u00a0signaling pathway AKTing up in schizophrenia","volume":"118","author":"Arguello","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature10658","article-title":"Mutations causing syndromic autism define an axis of synaptic pathophysiology","volume":"480","author":"Auerbach","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1535-7163.MCT-10-0654","article-title":"Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes","volume":"10","author":"Banerjee","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib5","doi-asserted-by":"crossref","first-page":"8862","DOI":"10.1523\/JNEUROSCI.1617-11.2011","article-title":"Loss of Tsc1 in\u00a0vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function","volume":"31","author":"Bateup","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib6","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","article-title":"The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination","volume":"19","author":"Benvenuto","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/ddi458","article-title":"Rapamycin alleviates toxicity of different aggregate-prone proteins","volume":"15","author":"Berger","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1440-1789.2008.00920.x","article-title":"Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex","volume":"28","author":"Boer","year":"2008","journal-title":"Neuropathology"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awf124","article-title":"Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex","volume":"125","author":"Bolton","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib11","first-page":"81","article-title":"Sclerose tubereuse des circonvolutions cerebrales: Idiotie et epilepsie hemiplegique","volume":"1","author":"Bourneville","year":"1880","journal-title":"Arch. Neurol. (Paris)"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/jmg.2004.024646","article-title":"Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations","volume":"42","author":"Butler","year":"2005","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib13","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib14","doi-asserted-by":"crossref","first-page":"16834","DOI":"10.1073\/pnas.0605296103","article-title":"A\u00a0genetic variant that disrupts MET transcription is associated with autism","volume":"103","author":"Campbell","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.nbd.2011.08.024","article-title":"Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin","volume":"45","author":"Carson","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.nbd.2011.12.028","article-title":"Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the DeltaRG mouse model of tuberous sclerosis complex","volume":"45","author":"Chevere-Torres","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.nbd.2011.07.018","article-title":"Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant\/negative form of tuberin","volume":"45","author":"Chevere-Torres","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib18","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1101\/gad.1685008","article-title":"Tuberous sclerosis complex proteins control axon formation","volume":"22","author":"Choi","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib19","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.1074\/jbc.C500451200","article-title":"TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase","volume":"281","author":"Chong-Kopera","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nn.2255","article-title":"Laminar and compartmental regulation of dendritic growth in mature cortex","volume":"12","author":"Chow","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuron.2008.10.055","article-title":"Translational control of long-lasting synaptic plasticity and memory","volume":"61","author":"Costa-Mattioli","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib22","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib23","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/WNL.0b013e3181e04325","article-title":"Biallelic TSC gene inactivation in tuberous sclerosis complex","volume":"74","author":"Crino","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.yebeh.2011.08.037","article-title":"Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis","volume":"22","author":"Cusmai","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/342718","article-title":"Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients","volume":"71","author":"Dabora","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib27","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","article-title":"Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial","volume":"17","author":"Davies","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molmed.2007.06.003","article-title":"The tuberous sclerosis complex proteins\u2013a GRIPP on cognition and neurodevelopment","volume":"13","author":"de Vries","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMc062928","article-title":"The tuberous sclerosis complex","volume":"356","author":"de Vries","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00787-006-0570-3","article-title":"The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families","volume":"16","author":"de Vries","year":"2007","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00787-005-0443-1","article-title":"Consensus clinical guidelines for the assessment of cognitive and behavioural problems in Tuberous Sclerosis","volume":"14","author":"de Vries","year":"2005","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ajmg.a.32690","article-title":"Neuropsychological attention deficits in tuberous sclerosis complex (TSC)","volume":"149A","author":"de Vries","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib33","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson's disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib34","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1523\/JNEUROSCI.0778-09.2009","article-title":"Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner","volume":"29","author":"Di Nardo","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0809-849","article-title":"Genetics and neuropsychiatric disorders: treatment during adulthood","volume":"15","author":"Ehninger","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10519-010-9398-1","article-title":"Increased levels of anxiety-related behaviors in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis","volume":"41","author":"Ehninger","year":"2011","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molmed.2010.10.002","article-title":"Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders","volume":"17","author":"Ehninger","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib39","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2788.2009.01208.x","article-title":"From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis","volume":"53","author":"Ehninger","year":"2009","journal-title":"J.\u00a0Intellect. Disabil. Res."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/mp.2010.115","article-title":"Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice","volume":"17","author":"Ehninger","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib41","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1023\/A:1025054610557","article-title":"Epidemiological surveys of autism and other pervasive developmental disorders: an update","volume":"33","author":"Fombonne","year":"2003","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib43","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib44","series-title":"GABAergic Interneuron Development and Function Is Modulated by the Tsc1 Gene","author":"Fu","year":"2011"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib45","doi-asserted-by":"crossref","first-page":"27527","DOI":"10.1074\/jbc.M701077200","article-title":"ERK and mTOR signaling couple beta-adrenergic receptors to translation initiation machinery to gate induction of protein synthesis-dependent long-term potentiation","volume":"282","author":"Gelinas","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1469-8749.1994.tb11765.x","article-title":"Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study","volume":"36","author":"Gillberg","year":"1994","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-642-18930-2_11","article-title":"mTOR signaling to translation","volume":"279","author":"Gingras","year":"2004","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib48","doi-asserted-by":"crossref","first-page":"18802","DOI":"10.1074\/jbc.M512524200","article-title":"Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons","volume":"281","author":"Gong","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib49","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.21317","article-title":"Cognitive deficits in Tsc1+\/\u2212 mice in the absence of cerebral lesions and seizures","volume":"62","author":"Goorden","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib50","doi-asserted-by":"crossref","first-page":"E1070","DOI":"10.1073\/pnas.1106454108","article-title":"Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex","volume":"108","author":"Goto","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib51","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1074\/jbc.M411768200","article-title":"Transgenic expression of dominant negative tuberin through a strong constitutive promoter results in a tissue-specific tuberous sclerosis phenotype in the skin and brain","volume":"280","author":"Govindarajan","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib52","doi-asserted-by":"crossref","first-page":"pe24","DOI":"10.1126\/scisignal.267pe24","article-title":"The pharmacology of mTOR inhibition","volume":"2","author":"Guertin","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib53","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature04724","article-title":"Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice","volume":"441","author":"Hara","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins","volume":"166","author":"Harrington","year":"2004","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib55","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<642::AID-AJMG12>3.0.CO;2-O","article-title":"Cognitive deficits in normally intelligent patients with tuberous sclerosis","volume":"88","author":"Harrison","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib56","doi-asserted-by":"crossref","first-page":"13796","DOI":"10.1073\/pnas.241184198","article-title":"FRAP\/mTOR is required for proliferation and patterning during embryonic development in the mouse","volume":"98","author":"Hentges","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/j.1601-183X.2012.00768.x","article-title":"Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome","author":"Hoeffer","year":"2012","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST0370217","article-title":"A\u00a0complex interplay between Akt, TSC2 and the two mTOR complexes","volume":"37","author":"Huang","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib59","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/MCB.00289-08","article-title":"The TSC1\u2013TSC2 complex is required for proper activation of mTOR complex 2","volume":"28","author":"Huang","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib60","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1469-8749.1987.tb02135.x","article-title":"Psychiatric disorder among children with tuberous sclerosis","volume":"29","author":"Hunt","year":"1987","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib61","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib62","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib63","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1528-1167.2005.00289.x","article-title":"Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes","volume":"46","author":"Jansen","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib64","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1523\/JNEUROSCI.2270-05.2005","article-title":"Control of dendritic arborization by the phosphoinositide-3'-kinase-Akt-mammalian target of rapamycin pathway","volume":"25","author":"Jaworski","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib65","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0883073807309788","article-title":"Characterization of autism in young children with tuberous sclerosis complex","volume":"23","author":"Jeste","year":"2008","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib66","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib67","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0033291702007092","article-title":"Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex","volume":"33","author":"Joinson","year":"2003","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1470-2045(07)70411-4","article-title":"Possible mechanisms of disease development in tuberous sclerosis","volume":"9","author":"Jozwiak","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib69","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","article-title":"Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex","volume":"15","author":"Jozwiak","year":"2011","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib70","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cmet.2010.05.001","article-title":"With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging","volume":"11","author":"Kapahi","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib71","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.0953-816x.2001.01664.x","article-title":"Requirement of appropriate glutamate concentrations in the synaptic cleft for hippocampal LTP induction","volume":"14","author":"Katagiri","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib72","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0092-8674(04)00115-1","article-title":"Translational control by MAPK signaling in long-term synaptic plasticity and memory","volume":"116","author":"Kelleher","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib73","first-page":"75","article-title":"Presence of a modifier gene(s) affecting early renal carcinogenesis in the Tsc2 mutant (Eker) rat model","volume":"24","author":"Kikuchi","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib74","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrn1557","article-title":"Biochemical mechanisms for translational regulation in synaptic plasticity","volume":"5","author":"Klann","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib75","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature04723","article-title":"Loss of autophagy in the central nervous system causes neurodegeneration in mice","volume":"441","author":"Komatsu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib76","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pediatrneurol.2009.08.001","article-title":"Diffusion features of white matter in tuberous sclerosis with tractography","volume":"42","author":"Krishnan","year":"2010","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib77","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib78","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1523\/JNEUROSCI.2284-05.2005","article-title":"Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways","volume":"25","author":"Kumar","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib79","doi-asserted-by":"crossref","first-page":"12923","DOI":"10.1073\/pnas.2132711100","article-title":"mTor is required for hypertrophy of Pten-deficient neuronal soma in\u00a0vivo","volume":"100","author":"Kwon","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib80","doi-asserted-by":"crossref","first-page":"16906","DOI":"10.1073\/pnas.0604994103","article-title":"Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning","volume":"103","author":"Lai","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib81","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/35010550","article-title":"The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho","volume":"2","author":"Lamb","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib82","doi-asserted-by":"crossref","first-page":"38121","DOI":"10.1074\/jbc.C500363200","article-title":"Glutamatergic regulation of the p70S6 kinase in primary mouse neurons","volume":"280","author":"Lenz","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib83","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.2003.012757","article-title":"Genotype and psychological phenotype in tuberous sclerosis","volume":"41","author":"Lewis","year":"2004","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib84","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib85","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0896-6273(01)00433-0","article-title":"A\u00a0role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala","volume":"31","author":"Lin","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib86","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","article-title":"Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis","volume":"121","author":"Ma","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib87","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib88","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","article-title":"A\u00a0mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival","volume":"27","author":"Meikle","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib89","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib90","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.yebeh.2007.07.010","article-title":"Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex","volume":"11","author":"Muzykewicz","year":"2007","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib91","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/jmg.2009.066852","article-title":"Deregulation of EIF4E: a novel mechanism for autism","volume":"46","author":"Neves-Pereira","year":"2009","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib92","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nn.2477","article-title":"Tsc2-Rheb signaling regulates EphA-mediated axon guidance","volume":"13","author":"Nie","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib93","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1212\/WNL.0b013e3182104347","article-title":"Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex","volume":"76","author":"Numis","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib94","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/adc.2003.026815","article-title":"The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex","volume":"89","author":"O'Callaghan","year":"2004","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib95","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","article-title":"Tsc2(+\/\u2212) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background","volume":"104","author":"Onda","year":"1999","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib96","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib97","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1356-9597.2004.00727.x","article-title":"Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function","volume":"9","author":"Oshiro","year":"2004","journal-title":"Genes Cells"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib98","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/08830738040190090601","article-title":"Behavioral and cognitive aspects of tuberous sclerosis complex","volume":"19","author":"Prather","year":"2004","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib99","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1126\/science.1131693","article-title":"Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites","volume":"314","author":"Raab-Graham","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib101","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/hmg\/ddl036","article-title":"Rapamycin pre-treatment protects against apoptosis","volume":"15","author":"Ravikumar","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib102","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nbd.2011.02.014","article-title":"Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration","volume":"43","author":"Reith","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib103","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/08830738040190090501","article-title":"Standardized whole brain mapping of tubers and subependymal nodules in tuberous sclerosis complex","volume":"19","author":"Ridler","year":"2004","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib104","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/cercor\/bhj144","article-title":"Neuroanatomical correlates of memory deficits in tuberous sclerosis complex","volume":"17","author":"Ridler","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib105","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature05291","article-title":"The roles of intracellular protein-degradation pathways in neurodegeneration","volume":"443","author":"Rubinsztein","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib106","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","article-title":"Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype\u2013phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex","volume":"13","author":"Sancak","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib107","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib108","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib109","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/ncb996","article-title":"Rheb promotes cell growth as a component of the insulin\/TOR signalling network","volume":"5","author":"Saucedo","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib110","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1523\/JNEUROSCI.1739-04.2004","article-title":"BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development","volume":"24","author":"Schratt","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib111","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","article-title":"Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies","volume":"14","author":"Shah","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib112","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1523\/JNEUROSCI.3696-09.2010","article-title":"Dysregulation of mTOR signaling in fragile X syndrome","volume":"30","author":"Sharma","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib113","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01048239","article-title":"Autism and tuberous sclerosis","volume":"22","author":"Smalley","year":"1992","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib114","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1023\/A:1026052421693","article-title":"Autism and tuberous sclerosis","volume":"28","author":"Smalley","year":"1998","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib115","doi-asserted-by":"crossref","first-page":"e9979","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib116","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ncb995","article-title":"Rheb is an essential regulator of S6K in controlling cell growth in Drosophila","volume":"5","author":"Stocker","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib117","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/neu.20152","article-title":"Local translational control in dendrites and its role in long-term synaptic plasticity","volume":"64","author":"Sutton","year":"2005","journal-title":"J.\u00a0Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib118","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbapap.2007.08.015","article-title":"Role of mTOR in physiology and pathology of the nervous system","volume":"1784","author":"Swiech","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib119","doi-asserted-by":"crossref","first-page":"9760","DOI":"10.1523\/JNEUROSCI.1427-04.2004","article-title":"Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites","volume":"24","author":"Takei","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1073\/pnas.012605299","article-title":"A\u00a0rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus","volume":"99","author":"Tang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib121","series-title":"Impaired Autophagy and Dendritic Spine Malformation in TSC Deficient Mice","author":"Tang","year":"2010"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib122","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/nn1566","article-title":"Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2","volume":"8","author":"Tavazoie","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib123","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib124","doi-asserted-by":"crossref","first-page":"37288","DOI":"10.1074\/jbc.M303257200","article-title":"Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase\/Akt-dependent and -independent phosphorylation of tuberin","volume":"278","author":"Tee","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10519-010-9423-4","article-title":"Neuropsychological attention skills and related behaviours in adults with tuberous sclerosis complex","volume":"41","author":"Tierney","year":"2011","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib126","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1212\/WNL.0b013e318247ca8d","article-title":"Everolimus alters white matter diffusion in tuberous sclerosis complex","volume":"78","author":"Tillema","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib127","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.10283","article-title":"Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures","volume":"52","author":"Uhlmann","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib128","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1601-183X.2005.00134.x","article-title":"Differential translation and fragile X syndrome","volume":"4","author":"Vanderklish","year":"2005","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib130","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.onc.1210693","article-title":"Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR","volume":"27","author":"Veverka","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib131","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000211721","article-title":"Zur Pathologie und pathologischen Anatomie der verschiedenen Idiotieformen","volume":"24","author":"Vogt","year":"1908","journal-title":"Monatsschr. Psychiatr. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib132","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1460-9568.2006.04594.x","article-title":"Impaired synaptic plasticity in a rat model of tuberous sclerosis","volume":"23","author":"von der Brelie","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib133","first-page":"1","article-title":"Ein Herz von einem Neugeborene welches mehrere theils nach aussen, theils nach den H\u00f6hlen prominirende Tumoren (Myomen) trug","volume":"20","author":"von Recklinghausen","year":"1862","journal-title":"Monatsschr. Geburtsheilkd."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib134","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.2005.03538.x","article-title":"Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis","volume":"96","author":"Waltereit","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib135","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s10519-010-9399-0","article-title":"Epilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in rats","volume":"41","author":"Waltereit","year":"2011","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib136","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2006.03.011","article-title":"A\u00a0role for the mTOR pathway in surface expression of AMPA receptors","volume":"401","author":"Wang","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib137","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/hmg\/ddp025","article-title":"Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse","volume":"18","author":"Way","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib138","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1469-8749.1996.tb12086.x","article-title":"Morbidity associated with tuberous sclerosis: a population study","volume":"38","author":"Webb","year":"1996","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib139","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tig.2010.02.004","article-title":"Coordinated control of the gene expression machinery","volume":"26","author":"White","year":"2010","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib140","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1023\/A:1026012414193","article-title":"Brief report: the association of neurofibromatosis type 1 and autism","volume":"28","author":"Williams","year":"1998","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib141","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/01.wnl.0000250330.44291.54","article-title":"Cognitive prognosis of patients with tuberous sclerosis complex","volume":"68","author":"Winterkorn","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib142","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/08830738060210020901","article-title":"Tuberous sclerosis complex: correlation of magnetic resonance imaging (MRI) findings with comorbidities","volume":"21","author":"Wong","year":"2006","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib143","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.10648","article-title":"Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model","volume":"54","author":"Wong","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib144","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2310\/7010.2006.00046","article-title":"Study of the relationship between tuberous sclerosis complex and autistic disorder","volume":"21","author":"Wong","year":"2006","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nbd.2009.01.010","article-title":"Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex","volume":"34","author":"Xu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib146","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/geno.2001.6654","article-title":"Genetic identification of a locus, Mot1, that affects renal tumor size in the rat","volume":"78","author":"Yeung","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.neuropharm.2012.05.015_bib147","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.braindev.2006.09.003","article-title":"Childhood autism and associated comorbidities","volume":"29","author":"Zafeiriou","year":"2007","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib148","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nbd.2007.07.015","article-title":"Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex","volume":"28","author":"Zeng","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib149","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib150","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/hmg\/ddq491","article-title":"Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex","volume":"20","author":"Zeng","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib151","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"Zhang","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2012.05.015_bib152","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ncb999","article-title":"Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins","volume":"5","author":"Zhang","year":"2003","journal-title":"Nat. Cell Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T18:53:43Z","timestamp":1713984823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812002006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":152,"alternative-id":["S0028390812002006"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.05.015","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}